Krsnaa Diagnostics Share Price

NSE
641.2
+0.15 (0.00%)
KRSNAA • 29 May, 2025 | 09:57 AM
BUY

1Y Annualised Return

13.42%

3Y Annualised Return

6.08%

The current prices are delayed, login or Open Demat Account for live prices.

Krsnaa Diagnostics SIP Return Calculator

Over the past

1 year
3 years

Total Investment of ₹65,00,000

Would have become ₹69,58,004 (+7.05%)

Daily SIP of 25,000 would have become 69,58,004 in 1 year with a gain of 4,58,004 (+7.05%)

Krsnaa Diagnostics Stock Performance
Today’s Low - High
638.80
642.70
638.80
642.70
52 Week Low - High
528.05
1,044.00
528.05
1,044.00

Open

641.00

Prev. Close

641.05

Total Traded Value

45.97 L

View details of Market Depth
Krsnaa Diagnostics Fundamental

Market Cap (in crs)

2,069.94

Face Value

5

Turnover (in lacs)

45.97

Key Metrics
Qtr Change %
38.69% Fall from 52W High
-10.6
Dividend yield 1yr %
Above industry Median
0.4

Krsnaa Diagnostics Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Krsnaa Diagnostics Quarterly Revenue

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
186.08 Cr
174.51 Cr
186.34 Cr
170.23 Cr
166.28 Cr

Krsnaa Diagnostics Yearly Revenue

Mar 2025Mar 2024Mar 2023Mar 2022
742.7 Cr
636.43 Cr
506.5 Cr
470.36 Cr

Krsnaa Diagnostics Quarterly Net Profit/Loss

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
20.68 Cr
19.42 Cr
19.6 Cr
17.92 Cr
18.73 Cr

Krsnaa Diagnostics Yearly Net Profit/Loss

Mar 2025Mar 2024Mar 2023Mar 2022
77.61 Cr
56.84 Cr
62.11 Cr
68.39 Cr
Krsnaa Diagnostics Result Highlights
  • Krsnaa Diagnostics Ltd reported a 7.1% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 22.6%.

  • Its expenses for the quarter were down by 6.5% QoQ and up 28.1% YoY.

  • The net profit decreased 3.6% QoQ and decreased 1.0% YoY.

  • The earnings per share (EPS) of Krsnaa Diagnostics Ltd stood at 5.7 during Q4FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Krsnaa Diagnostics shareholding Pattern

Promoter
27.2%
Foreign Institutions
3.6%
Mutual Funds
9.4%
Domestic Institutions
14.2%
Public
54.9%
Promoter
27.2%
Foreign Institutions
4%
Mutual Funds
9.8%
Domestic Institutions
14.5%
Public
54.3%
Promoter
27.2%
Foreign Institutions
3.6%
Mutual Funds
11.6%
Domestic Institutions
15.9%
Public
53.3%
Promoter
27.2%
Foreign Institutions
3.3%
Mutual Funds
11.9%
Domestic Institutions
15.3%
Public
54.2%
Promoter
27%
Foreign Institutions
3.3%
Mutual Funds
11%
Domestic Institutions
15.4%
Public
54.3%
Promoter
27%
Foreign Institutions
3.4%
Mutual Funds
11.9%
Domestic Institutions
16.6%
Public
52.9%

Krsnaa Diagnostics Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
641.2
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
644.80
10Day EMA
653.90
12Day EMA
658.60
20Day EMA
676.90
26Day EMA
688.40
50Day EMA
720.70
100Day EMA
757.50
200Day EMA
766.60
5Day SMA
644.10
10Day SMA
646.50
20Day SMA
678.70
30Day SMA
712.50
50Day SMA
735.80
100Day SMA
774.80
150Day SMA
823.60
200Day SMA
811.60
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
45221 Rs
76093 Rs
Week Rs
47134 Rs
79471 Rs
Month Rs
77364 Rs
140577 Rs
Resistance & Support
644.23
Pivot
Resistance
First Resistance
650.32
Second Resistance
659.58
Third Resistance
665.67
Support
First Support
634.97
Second support
628.88
Third Support
619.62
Relative Strength Index
35.12
Money Flow Index
26.48
MACD
-29.75
MACD Signal
-28.49
Average True Range
25.73
Average Directional Index
38.28
Rate of Change (21)
-14.71
Rate of Change (125)
-37.16
Shareholding
Name
Holding Percent
TATA MUTUAL FUND - TATA SMALL CAP FUND
7.73
BANDHAN BSE HEALTHCARE INDEX FUND
1.32
K INDIA OPPORTUNITIES FUND LIMITED PCC - CELL S
2.19
HDFC LIFE INSURANCE COMPANY LIMITED
2.06

Krsnaa Diagnostics Latest News

20 MAY 2025 | Tuesday

Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

19 MAY 2025 | Monday

Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

15 MAY 2025 | Thursday

Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

View More

Krsnaa Diagnostics Company background

Founded in: 2010
Managing director: Pallavi Bhatevara,
Krsnaa Diagnostics Limited was originally incorporated as Krsna Diagnostics Private Limited at Pune, Maharashtra dated December 22, 2010. The Company name was changed to Krsnaa Diagnostics Private Limited, pursuant to a fresh Certificate of Incorporation issued by the RoC on January 29, 2015. Thereafter, the status got converted into a Public Company and the name was changed to Krsnaa Diagnostics Limited pursuant to a fresh Certificate of Incorporation issued by the RoC on 06 May, 2021. The Company is primarily engaged in providing diagnostic services centres all over India. The company is providing Radiology and Pathology services for Xray, CT Scan, MRI, Mammography, TeleReporting services, all type of blood and urine investigation and other related diagnostic services. The Company owns an extensive network of integrated diagnostics centres across India primarily in nonmetro and lowertier cities and towns, with operating 1823 diagnostics centres offering radiology and pathology services in 13 states across the country. The Company started operating 12 centres in Himachal Pradesh in public private partnership during the period 2012. It installed 50 centres in 4 states in 2017 and expanded operations across 13 states in 2018. Further, it expanded the operations to over 1500 centres across India in 2020. The Company in August 2021, came up with an Initial Public Offer of 12,741,036 Equity Shares by raising funds from public aggregating to Rs.1213.33 Crore, comprising a Fresh Issue of 4,215,516 Equity Shares aggregating to Rs 400 Crore and an Offer for Sale of 8,525,520 Equity Shares aggregating to Rs. 813.33 Crore.The Company operationalized 26 radiology centers, 50 pathology labs, and 556 collection centers in 202223. It expanded geographical presence from 660+ centers in FY 2018 to over 2,800 centers in FY 2023. The Teleradiology hub in Pune achieved prestigious accreditationfrom the National Accreditation Board for Hospitals Healthcare Providers (NABH) during the year 2023. The Company expanded its geographical presence to more than 3600 centres in FY 2024.
Read More

Krsnaa Diagnostics FAQs

Krsnaa Diagnostics share price is ₹641.3 in NSE and ₹641 in BSE as on 29/5/2025.

Krsnaa Diagnostics share price in the past 1-year return was 11.87. The Krsnaa Diagnostics share hit a 1-year low of Rs. 528.05 and a 1-year high of Rs. 1044.

The market cap of Krsnaa Diagnostics is Rs. 2069.94 Cr. as of 29/5/2025.

The PE ratios of Krsnaa Diagnostics is 24.98 as of 29/5/2025.

The PB ratios of Krsnaa Diagnostics is 2.31 as of 29/5/2025

The Mutual Fund Shareholding in Krsnaa Diagnostics was 9.36% at the end of 29/5/2025.

You can easily buy Krsnaa Diagnostics shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Krsnaa Diagnostics stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -